Negative allosteric modulators (nams) of metabotropic glutamate receptors 2 & 3 (MGLU2/3) for the treatment of depression
Ended Project Grant Awarded Last action
- Award ID
- R43MH122063
- Recipient
-
Camino Pharma LLC UEI K6JUDA59JJ17
- Awarding agency
-
National Institute of Mental Health
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,725,909
Award facts
- Assistance listing
- 93.242 Mental Health Research Grants
- Completion date
- Originally
- Funding
-
- $1,276,455.52 Federal
- $449,453.00 Non-federal
- Place of performance
- San Diego, CA 92122, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$92,313 | $0 | |
| Amendment | $449,453 | $0 | |
| Amendment | $449,453 | $449,453 | |
| Original award | $469,863 | $0 |
Quick answers
Who received award R43MH122063?
R43MH122063 was awarded to Camino Pharma LLC by National Institute of Mental Health (National Institutes of Health) on June 5, 2020.
How much is award R43MH122063 worth?
$1,725,909 has been obligated on R43MH122063: $1,276,456 in federal funding and $449,453 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award